219 related articles for article (PubMed ID: 10219072)
1. Does Pneumocystis carinii prophylaxis still need to be lifelong?
Masur H; Kaplan J
N Engl J Med; 1999 Apr; 340(17):1356-8. PubMed ID: 10219072
[No Abstract] [Full Text] [Related]
2. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
[TBL] [Abstract][Full Text] [Related]
3. Immune reconstitution in several forms.
Ball SC
AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
[No Abstract] [Full Text] [Related]
4. OI prophylaxis in antiretroviral responders: stay the course or bite the bullet?
Currier JS
AIDS Clin Care; 1998 Oct; 10(10):73-5, 79-80. PubMed ID: 11365859
[TBL] [Abstract][Full Text] [Related]
5. Update on opportunistic infections.
Proj Inf Perspect; 1997 Nov; (23):16-7. PubMed ID: 11365373
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy.
Gill J; Moyle G; Nelson M
AIDS; 1998 Apr; 12(6):680. PubMed ID: 9583614
[No Abstract] [Full Text] [Related]
8. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
Le Moal G; Breux JP; Roblot F
N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
[No Abstract] [Full Text] [Related]
9. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
Bender MA; Sax PE
N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
[No Abstract] [Full Text] [Related]
10. Pneumocystis carinii pneumonia in HIV-infected patients.
May TA; Gruta CI; Goldschmidt RH
Am Fam Physician; 2000 Oct; 62(8):1783, 1786. PubMed ID: 11057837
[No Abstract] [Full Text] [Related]
11. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal of prophylaxis against Pneumocystis carinii pneumonia.
Feinberg J
Lancet; 1999 Apr; 353(9161):1287. PubMed ID: 10218521
[No Abstract] [Full Text] [Related]
14. P. carinii prophylaxis in patients with HIV.
Kirchner JT
Am Fam Physician; 1999 Nov; 60(7):2094-5. PubMed ID: 10569511
[No Abstract] [Full Text] [Related]
15. Stopping preventive treatments.
Fornataro K; Jefferys R
Body Posit; 1999 Jul; 12(7):9-10. PubMed ID: 11367080
[TBL] [Abstract][Full Text] [Related]
16. Opportunistic infections: stemming the tide.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):42-7. PubMed ID: 11364202
[TBL] [Abstract][Full Text] [Related]
17. Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics.
Maserati R; Villani P; Cocchi L; Regazzi MB
AIDS; 1998 May; 12(7):815-6. PubMed ID: 9619815
[No Abstract] [Full Text] [Related]
18. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
Miller RF
Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633
[No Abstract] [Full Text] [Related]
19. [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
García Vázquez E; de Górgolas Hernández M; García Delgado R; Fernández Guerrero ML
Med Clin (Barc); 1999 Jun; 113(3):89-90. PubMed ID: 10464742
[TBL] [Abstract][Full Text] [Related]
20. [Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
Sáiz Hervas E; Castilla Castellano V; Miquel Plaza J; Benito Blanco AM; Martín Llorens MM; Pastor de Blas M; Izquierdo P; Muñoz Jareño MA; Sierra A; Nieto MA; Moreno Collado AM; Fraguas C
An Med Interna; 1998 Mar; 15(3):132-7. PubMed ID: 9580410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
